Ironing out delivery wrinkles, Galderma posts phase 3 wins for liquid botulinum toxin A on route to FDA Chasing Sage, PureTech’s oral depression drug clears early bioavailability test Biologics delivery startup Elektrofi bags $40M for clinical push Bacteria-triggered drug release system clears preclinical tests The top 10 most profitable pharma companies in 2021 'The Top Line' podcast: ASCO data that wowed, rising stars blurring the line between traditional and tech-enabled drugs, plus this week’s headlines Featured Story | By Nick Paul Taylor Galderma has chalked up a pair of phase 3 wins for its liquid formulation botulinum toxin A, positioning it to submit the candidate for approval in the U.S. and other global markets. The formulation is designed to eliminate the need to reconstitute the aesthetic treatment from powder. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor PureTech Health has cleared an early hurdle in its pursuit of Sage Therapeutics, linking its oral prodrug of allopregnanolone to a nine-fold increase in the blood levels achieved by the unmodified molecule. Based on the data, the company is forging ahead with a view to starting a phase 1b/2a clinical trial next year. read more By Nick Paul Taylor Elektrofi has secured funding to support the advance of candidates based on its drug delivery technology into the clinic. Having landed deals with companies including Argenx and Takeda, the biologics delivery specialist has raised $40 million to establish a GMP manufacturing line and double its head count. read more By Nick Paul Taylor Researchers have developed a hydrogel that releases its payload when exposed to enzymes produced by certain bacteria, opening the door to a smart drug delivery system that could help minimize the risk of drug resistance. read more By Angus Liu,Eric Sagonowsky,Kevin Dunleavy,Fraiser Kansteiner,Zoey Becker While revenue reflects how well a pharma company’s products and services are selling, profit represents another important measurement that provides investors a look at the health of the business and how efficiently it has been managed. Here, we rank the top 10 pharma companies by 2021 net income. read more By Teresa Carey This week on "The Top Line," we discuss our special report on the rising stars in the digital health sector. We also talk about surprising data from this weekend’s ASCO meeting and the week's other big headlines. Plus, we're back in person at the biggest conferences! read more Resources Sponsored by: PwC Don’t miss these critical considerations when evaluating your HCP interactions management program. Sponsored by: Merit Solutions Quality operations guide your organization through regulatory compliance processes and safeguard your products, processes, and reputation. But your team is capable of so much more. Quality incident data and processes can be a driver of significant business value if shared with other stakeholders. Sponsored by: Blue Matter, strategic consultants in the life sciences Recent trends are driving big changes in Medical Affairs. This paper explores why, and what MA teams can do to stay ahead of the curve. Sponsored by: Catalent Did you know Catalent has newly expanded in-house capabilities spanning clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays? Sponsored by: Catalent Orally Inhaled & Nasal Drug Delivery: A Pipeline of Opportunities Sponsored by: Catalent What are key considerations for intranasal delivery in the treatment of acute and chronic conditions? AI Driven Drug Discovery Summit August 16-17, 2022 Fierce Health Payer Summit October 12, 2022 | Free Virtual Event Fierce Biotech Cell & Gene Therapy Forum October 19, 2022 | Virtual Event Drug Development Boot Camp® 2022 November 16-17, 2022 Fierce Launch Readiness for Medical Affairs & Communications Teams Summit November 30-December 1, 2022 | Free Virtual Event | 